Literature DB >> 16983661

pH is an intracellular effector controlling differentiation of oligodendrocyte precursors in culture via activation of the ERK1/2 pathway.

Frédéric Bernard1, Peter Vanhoutte, Amar Bennasroune, Gérard Labourdette, Martine Perraut, Dominique Aunis, Stéphane Gaillard.   

Abstract

We reported previously that onset of oligodendrocyte precursor cell (OPC) differentiation is accompanied by an increase in intracellular pH (pH(i)). We show that OPC differentiation is dependent primarily on a permissive pH(i) value. The highest differentiation levels were observed for pH(i) values around 7.15 and inhibition of differentiation was observed at slightly more acidic or alkaline values. Clamping the pH(i) of OPCs at 7.15 caused a transient activation of ERK1/2 that was not observed at more acidic or alkaline values. Furthermore, inhibition of ERK activation with the UO126 compound totally prevented OPC differentiation in response to pH(i) shift. These results indicate that pH(i), acting through the ERK1/2 pathway, is a key determinant for oligodendrocyte differentiation. We also show that this pH(i) pathway is involved in the process of retinoic acid-induced OPC differentiation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16983661     DOI: 10.1002/jnr.21051

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  2 in total

Review 1.  Hydrogen Ion Dynamics as the Fundamental Link between Neurodegenerative Diseases and Cancer: Its Application to the Therapeutics of Neurodegenerative Diseases with Special Emphasis on Multiple Sclerosis.

Authors:  Salvador Harguindey; Khalid Alfarouk; Julián Polo Orozco; Stephan J Reshkin; Jesús Devesa
Journal:  Int J Mol Sci       Date:  2022-02-23       Impact factor: 5.923

2.  Extracellular acidic pH inhibits oligodendrocyte precursor viability, migration, and differentiation.

Authors:  Anna Jagielska; Kristen D Wilhite; Krystyn J Van Vliet
Journal:  PLoS One       Date:  2013-09-30       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.